Tata Institute’s groundbreaking cancer treatment pill promises to prevent recurrence and reduce side effects, offering hope and affordability to millions.
Table of Contents
Introducton: Tata Institute’s Cure For Cancer
Mumbai: In a significant breakthrough in cancer treatment, the Tata Institute has announced a pioneering discovery after a decade of research. They have developed a revolutionary pill that can potentially prevent cancer recurrence and reduce treatment side effects by up to 50%. Termed as a breakthrough discovery, the research and medical team at Tata Institute have advanced a tablet, claiming it could halt cancer recurrence. Further elaborating, they stated that it could significantly mitigate the side effects of treatments like radiation and chemotherapy.
also read: Why Negotiation Skills Are Important? : Unlocking Success In Every Sphere
Tata Institute’s Cure For Cancer: Brief
- Named ‘ARC+CU’, this tablet contains resveratrol and copper alongside pro-oxidant elements, generating oxygen radicals in the stomach. These radicals effectively destroy chromatin particles released by dying cancer cells, thereby preventing healthy cells from becoming cancerous. This process also inhibits the spread of cancer cells from one part of the body to another, a phenomenon known as metastasis.
- Affordable for the Masses: During media briefings, doctors at Tata Memorial Hospital highlighted that the tablet’s side effects are currently being tested on rodents, with promising results. However, human trials are yet to be completed. They also mentioned that the tablet awaits approval from the Food Safety and Standards Authority of India (FSSAI).
- The introduction of this tablet into the market could be immensely beneficial to the public. Cancer treatment incurs costs in the millions to the billions range, making it financially burdensome for many. It is hoped that this tablet will be available for just 100 rupees, making it accessible to a large population.
- This groundbreaking development not only offers hope to cancer patients but also signifies a significant leap in medical science. With further testing and approvals, it holds the potential to revolutionize cancer treatment globally, offering a more effective and affordable solution to millions affected by this disease.
Conclusion: Tata Institute’s Cure For Cancer
The journey from research labs to pharmacy shelves showcases the power of relentless pursuit of knowledge and innovation in tackling some of humanity’s most daunting challenges. As the world eagerly awaits the outcome of human trials and regulatory approvals, the prospect of a more effective and accessible cancer treatment looms brighter on the horizon.
Source: टाटा इंस्टीट्यूट ने खोजी दवा, 100 रुपये के गोली से होगा कैंसर का इलाज
